Global Health

Sophie Elisabeth Müller

Tel.: +49 (0) 6841 16-23925
Fax: +49 (0) 6841 16-23985
E-Mail: sophieElisabeth.Mueller@uks.eu

 

 

Univ.-Prof. Dr. med. Dr. phil. Sören Becker

Tel.: +49 (0) 6841 16-23900
Fax: +49 (0) 6841 16-23985
E-Mail: mikrobiologie@uks.eu

 

 

Current projects:

  • Provision of high-quality and accurate microbiological diagnostics for rapid and accurate identification of causative agents in bacteremia and other severe infections in Côte d’Ivoire, Nigeria, Guinea-Bissau, Lesotho and Madagascar

  • One health assessment of the epidemiology of multidrug-resistant Gram-negative bacteria in human, animal, and environmental samples from Côte d’Ivoire, Nigeria, Guinea-Bissau through whole-genome sequencing (WGS) and metagenomics.

  • Antimicrobial stewardship (AMS) initiatives to optimize use of novel antimicrobials in Côte d’Ivoire, Nigeria, Guinea-Bissau

Selected publications by members of the research group covering this topic:

A preliminary analysis of hand disinfection use by travellers and their colonisation-risk with multi-resistant bacteria: A proof-of-concept study

Tobias Kaspers, Cosima Berdin, Thérèse Staub, Barbara Gärtner, Fabian Berger, Alexander Halfmann, Sören L Becker, Sophie Schneitler (2025)

Travel Med Infect Dis.

DOI: 10.1016/j.tmaid.2025.102837 

Establishment of a national travel medicine vaccination network to assess reactogenicity of new and rarely used vaccines: a TropNet study

Clara Köpke, Camilla Rothe, Andreas Zeder, Gerhard Boecken, Torsten Feldt, Christian Janke, Sabine Jordan, Micha Löbermann, Andreas Müller, Hans-Martin Orth, Luise Marie Prüfer-Krämer, Johannes Schäfer, Günther Slesak, August Stich, Sabine Bélard, Nico Thul, Sören L Becker, Sophie Schneitler; TravVacNet-Group. (2024)

J Travel Med. 

DOI: 10.1093/jtm/taae092 
 

Vaccine certificates for international travelers in future pandemics

Rafael Dal-Ré, Sören L. Becker, Odile Launay, Androula Pavli (2023)

 

Eur J Clin Microbiol Infect Dis. 42(2):227-228

DOI: 10.1007/s10096-022-04544-y

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

Rafael Dal-Ré, Sören L Becker, Emmanuel Bottieau, Søren Holm (2022)

 

Lancet Infect Dis. 22(8):e231-e238

DOI: 10.1016/S1473-3099(22)00119-0

SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals

Rebecca Urschel, Saskia Bronder, Verena Klemis, Stefanie Marx, Franziska Hielscher, Amina Abu-Omar, Candida Guckelmus, Sophie Schneitler, Christina Baum, Sören L Becker, Barbara C Gärtner, Urban Sester, Leonardo Martinez, Marek Widera, Tina Schmidt, Martina Sester (2024)

Nat Commun. 15(1):3077

DOI: 10.1038/s41467-024-47429-8 
 

Diagnostic Specificity of Two Dengue Virus IgG ELISAs after Yellow Fever and Japanese Encephalitis Virus Vaccination

Isabelle Schnabel, Sophie Schneitler, Tom Schüttoff, Henning Trawinski, Christoph Lübbert, Christian Jassoy (2022)

 

Trop Med Infect Dis. 8(1):7

DOI: 10.3390/tropicalmed8010007

Application of a POC-CCA rapid diagnostic test and serology for detection of schistosomiasis in HIV-positive individuals in urban Malawi

Sören L. Becker, Stefan F. Weber, Andrew de Forest, Sam Phiri, Petra Förster, Angellina Nhlema, Claudia M. Denkinger, Anna Nimmesgern, Florian Neuhann (2021)

 

Acta Tropica 224:106142

DOI: 10.1016/j.actatropica.2021.106142

Experiences with pre-travel diagnostic PCR testing for SARS-CoV-2: Challenges and opportunities

Sophie Schneitler, Jana Gülker, Farah Alhussein, Florian Bub, Alexander Halfmann, Lisa Klein, Sophie Roth, Philipp Jung, Sören L. Becker (2021)

 

J Travel Med. 28(7):taab116

DOI: 10.1093/jtm/taab116

Funding sources:

  • Global Health EDCTP3
  • Federal state of Saarland, state research funding